bpc-157 legal status united states 2025 FDA's Review Of Peptides Signals A Growing Public Health Challenge BPC-157 for athletes and injury

The regulatory landscape for BPC-157 includes its listing by the World Anti-Doping Agency (WADA) as a prohibited substance, reflecting concerns about its potential to enhance sports performance and accelerate recovery from musculoskeletal injury models

BPC-157 promotes angiogenesis through upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) and activation of the VEGFR2-Akt-eNOS signaling cascade, leading to increased nitric oxide production essential for endothelial proliferation and new blood vessel formation

Beyond wound healing, BPC-157 helps protect the gastrointestinal tract, prevents stomach ulcers, and supports systemic repair across multiple tissue types

Freezing at -20C (-4F) extends stability further for long-term storage

Patients with a prior history of serious gastrointestinal adverse events and other known risk factors that are associated with peptic ulcer disease ( alcoholism, smoking) are at increased risk